Avastin in Combination With Radiation and Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma Multiformes and Gliosarcomas
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary) ; Irinotecan
- Indications Glioblastoma; Glioma; Gliosarcoma
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Apr 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 17 Jan 2013 Planned end date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.